Sine die came for Oregon’s 2026 legislative session last Friday, March 6th. I previewed the roster of cannabis bills in play back on February 12th. Two of them passed; two of them failed. Below is a recap of the action, with links to each bill in the headers. HB 4139 (FAILED) This was the session’s
Last month, we hosted a webinar on federal cannabis law and policy in 2026. While things are not where we’d like them to be, it’s amazing to consider everything that has happened over the years. From a lawyering perspective, it’s almost unbelievable. I have worked as a business lawyer in the cannabis industry for over
U.S. federal cannabis law is at a pivotal moment heading into 2026. In a January 15th webinar, attorneys Jason Adelstone and Vince Sliwoski examined two major federal developments that are poised to reshape the industry: the Executive Order directing the rescheduling of marijuana under the Controlled Substances Act, and new Congressional legislation redefining “hemp,” effective
What long resembled a Never Ending Story has finally reached a turning point. Today, President Trump signed an Executive Order directing the Attorney General to reschedule marijuana as a Schedule III substance under the Controlled Substances Act (CSA). The signing and remarks can be viewed here. The order includes the following directives (as first reported
Thailand’s political landscape shifted decisively on September 5, 2025, when Anutin Charnvirakul secured appointment as Prime Minister with support from 311 of 492 House Representatives. Under an agreement with the People’s Party, Anutin will serve a four-month term before calling new elections—a brief window that could prove pivotal for the nation’s cannabis industry. For cannabis
In the never-ending loop of federal marijuana reform debates, one crucial fact keeps getting overlooked: the Attorney General (AG) has the power to reschedule marijuana. Right now. No act of Congress. No HHS review. No rulemaking marathon. Just a signature. Under 21 U.S.C. § 811(d)(1), the AG can unilaterally reschedule marijuana to better align U.S.
After attending the International Cannabis Business Conference (ICBC) in Berlin at the end of April, I was reminded, yet again, of how draconian U.S. marijuana laws truly are. The excitement throughout the event was palpable. Much of it was driven by Germany’s newly formed government keeping its quasi-legalization policy intact, even if adult-use trials remain
Our cannabis business attorneys regularly handle transactions involving the purchase and sale of licensed cannabis businesses. These deals often move fast, with brokers rushing both sides toward closing—frequently without regard for applicable diligence and cannabis regulations. The worst-case scenario is when a company comes to us after executing a seller drafted purchase agreement without having
On Thursday, November 7th, Vince Sliwoski and Fred Rocafort held a post election discussion “Post-Election Cannabis Wrap – Smoke ’em if You’ve Got ’em”. Watch the replay! Key Takeaways from the “Smoke ’em if You’ve Got ’em – 2024 Post Election Cannabis Wrap” Webinar: Panelists: Vince Sliwoski: Oregon Business lawyer specializing in cannabis and commercial
Last Thursday, we learned that the DEA’s marijuana rescheduling hearings are delayed until early next year. We also saw the list of 25 participants invited by the DEA to testify at those hearings. The takeaways here are: a) we will not have a substantive hearing on marijuana rescheduling until a new President takes office, and
